Dörr, F.
1261  Ergebnisse:
Personensuche X
?
1

Speech Biomarkers for Dysarthria in Parkinson's Disease — C..:

Baykara, E. ; Dörr, F. ; Rusz, J...
Parkinsonism & Related Disorders.  122 (2024)  - p. 106726 , 2024
 
?
2

P2.19-01 First-in-Human Phase 1 Trial of VT3989, a First-in..:

Yap, T. ; Desai, J. ; Dagogo-Jack, I....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S384 , 2023
 
?
 
?
6

Epiduraler spinaler Abszeß mit Kaudasymptomatik als Komplik..:

Frank, B. ; Dörr, F. ; Penkert, G...
DMW - Deutsche Medizinische Wochenschrift.  116 (2008)  35 - p. 1313-1316 , 2008
 
?
8

Dose ranging pharmacokinetic trial of high‐dose alicaforsen..:

Yacyshyn, B. R. ; Barish, C. ; Goff, J....
Alimentary Pharmacology & Therapeutics.  16 (2002)  10 - p. 1761-1770 , 2002
 
?
9

Association of c-Raf expression with survival and its targe..:

McPhillips, F ; Mullen, P ; Monia, B P...
British Journal of Cancer.  85 (2001)  11 - p. 1753-1758 , 2001
 
?
10

Tamoxifen and fenretinide in women with metastatic breast c..:

Zujewski, J. ; Pai, L. ; Wakefield, L....
Breast Cancer Research and Treatment.  57 (1999)  3 - p. 277-283 , 1999
 
?
11

Metastatic bladder cancer: Advances in treatment:

Stadler, W.M. ; Kuzel, T.M. ; Raghavan, D....
European Journal of Cancer.  33 (1997)  - p. S23-S26 , 1997
 
?
 
?
 
?
 
?
15

Potential Role of Tamoxifen in Prevention of Breast Cancer:

Nayfield, S. G. ; Karp, J. E. ; Ford, L. G...
JNCI Journal of the National Cancer Institute.  83 (1991)  20 - p. 1450-1459 , 1991
 
1-15